Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma
ADP-ribosylation factor (Arf)-GTPase-activating protein (GAP) with coiled-coil, ankyrin repeat and PH domains 1 (ACAP1) has been reported to serve as an adaptor for clathrin coat complex playing a role in endocytic recycling and cellular migration. The potential role of ACAP1 in lung adenocarcinoma...
Main Authors: | Ning Wang, Lingye Zhu, Xiaomei Xu, Chang Yu, Xiaoying Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037022003592 |
Similar Items
-
ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors
by: Qiyi Yi, et al.
Published: (2022-12-01) -
Tumor lymphangiogenesis index reveals the immune landscape and immunotherapy response in lung adenocarcinoma
by: Weichang Yang, et al.
Published: (2024-04-01) -
Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma
by: Ning Wang, et al.
Published: (2023-06-01) -
Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma
by: Xiangqian Zhang, et al.
Published: (2023-06-01) -
Identification of a coagulation‐related signature correlated with immune infiltration and their prognostic implications in lung adenocarcinoma
by: Siqian Yang, et al.
Published: (2023-11-01)